Dr. Reddy’s secures U.S. FDA tentative nod for HIV drug lenacapavir
The Hindu

The Hindu

Several outlets reported this. AI can compare where they agree and differ.
EconomyTimes of India
A breakthrough HIV drug has seen 18 patent filings, which may delay the availability of affordable generics.
MarketsEconomic Times
MarketsEconomic Times
Track live updates and stock performance data for Dr. Reddy's Laboratories shares on financial markets.
MarketsCNBC-TV18
The US FDA has classified the inspection of Aurobindo Pharma's step-down subsidiary Lannett Company LLC as OAI after issuing four observations during an August inspection. Aurobindo Pharma said it responded to the observations within the stipulated time and that the regulatory action has no impact on its financials or operations.
EconomyThe Hindu
The acquisition will take it beyond active pharmaceutical ingredients into finished formulations and give it a licensed operating business in Germany.
EconomyThe Hindu
BDR Pharma is set to acquire a stake in Acme's oral solid formulations business.
EconomyCNBC-TV18
Natco Pharma reported a decline in net profit and revenue from last year and declared a second interim dividend.
Hindustan Times
The Union ministry of health and family welfare has proposed immediately suspending licences of those drug manufacturers whose products were classified as “not of standard quality” (NSQ) after failing to meet certain specified parameters